9 nov 2021
CPhI Worldwide 2021
Jiangsu Hengrui Medicine Co., Ltd.

Jiangsu Hengrui Medicine Co., Ltd.

Exhibitor at CPhI Worldwide 2021 stand stand 1F61

About us

     Hengrui Medicine is a leading pharmaceutical company based in China with a focus on research, development, manufacturing, and commercialization of innovative and high-quality healthcare products. In 1997, it was restructured into a joint-stock company. In 2000 Hengrui was listed on Shanghai Stock Exchange under stock code 600276. The company ranks top 30 worldwide in pharmaceuticals industry by a market capitalization of over 55 billion USD, and is home to more than 21,900 employees worldwide. Hengrui stands out as a...

Specs about this supplier

Sales markets Middle East Region (e.g. UAE); Oceania; North America (USA, Canada); Africa; Central America (e.g. Mexico); East Asia (e.g. China, Japan, Korea); Europe - EU countries; Europe - non EU (e.g. UK, Russia, ex-CIS countries); South America (e.g. Brazil, Colombia); South Asia (e.g. India, Pakistan, Sri Lanka); South East Asia (e.g. Thailand, Philippines, Singapore)
Affiliated categories: APIs (Active Pharmaceutical Ingredients) |Finished Dosage Forms |Injectables More

Products featured at CPhI Worldwide 2021

Categories affiliated with Jiangsu Hengrui Medicine Co., Ltd.

Jiangsu Hengrui Medicine Co., Ltd.

Event information

CPhI Worldwide 2021

9-11 November 2021 Fiera Milano, Milan, Italy Visit us at stand 1F61